Payment overview · 2025
General Payments
$81.68
5 reported records · 5 companies
Healthcare provider profile · identity verified
David E Thompson, MD
Allopathic & Osteopathic Physicians|Internal Medicine · BRISTOL, TN · NPI 1558331033
Verified facts
What the public records show
CMS Open Payments records show David E Thompson, MD received $81.68 in general payments during 2025 across 5 reported records.
Medtronic, Inc. accounted for 30.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 199 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$24.91 | 30.5% | 1 | 2025 |
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $17.49 | 21.4% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $15.31 | 18.7% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $13.56 | 16.6% | 1 | 2025 |
| CeQur Corporation | Unresolved — no canonical attribution shown | $10.41 | 12.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $81.68 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MINIMED 780G Normalized: minimed 780g |
Device | Medtronic, Inc. | $24.91 | 1 | 2025 |
Source payment records
|
|||||
| EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Normalized: epi sense guided coagulation system with visitrax |
Device | AtriCure, Inc. | $17.49 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $15.31 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $15.31 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $13.56 | 1 | 2025 |
Source payment records
|
|||||
| CeQur Simplicity Normalized: cequr simplicity |
Device | CeQur Corporation | $10.41 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 199 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
199 | 35 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 564 | 135 |
| Amlodipine Besylate | Amlodipine Besylate | 449 | 115 |
| Losartan Potassium | Losartan Potassium | 383 | 97 |
| Lisinopril | Lisinopril | 382 | 97 |
| Alprazolam | Alprazolam | 359 | 54 |
| Omeprazole | Omeprazole | 352 | 94 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 344 | 103 |
| Pantoprazole Sodium | Pantoprazole Sodium | 320 | 89 |
| Furosemide | Furosemide | 311 | 88 |
| Atorvastatin Calcium | Atorvastatin Calcium | 306 | 79 |
| Gabapentin | Gabapentin | 292 | 57 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 277 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 270 | 80 |
| Trazodone Hcl | Trazodone Hcl | 263 | 66 |
| Metformin Hcl | Metformin Hcl | 244 | 62 |
| Eliquis | Apixaban | 238 | 46 |
| Pravastatin Sodium | Pravastatin Sodium | 235 | 65 |
| Montelukast Sodium | Montelukast Sodium | 222 | 58 |
| Metoprolol Tartrate | Metoprolol Tartrate | 216 | 58 |
| Zolpidem Tartrate | Zolpidem Tartrate | 202 | 31 |
| Ozempic | Semaglutide | 199 | 35 |
| Escitalopram Oxalate | Escitalopram Oxalate | 194 | 49 |
| Tamsulosin Hcl | Tamsulosin Hcl | 187 | 58 |
| Jardiance | Empagliflozin | 180 | 36 |
| Meloxicam | Meloxicam | 179 | 49 |
| Metoprolol Succinate | Metoprolol Succinate | 175 | 48 |
| Glimepiride | Glimepiride | 169 | 41 |
| Metformin Hcl Er | Metformin Hcl | 164 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 157 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 150 | 39 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 137 | 17 |
| Synthroid | Levothyroxine Sodium | 125 | 25 |
| Atenolol | Atenolol | 119 | 30 |
| Potassium Chloride | Potassium Chloride | 119 | 38 |
| Pioglitazone Hcl | Pioglitazone Hcl | 116 | 28 |
| Lorazepam | Lorazepam | 115 | 17 |
| Sertraline Hcl | Sertraline Hcl | 109 | 30 |
| Tramadol Hcl | Tramadol Hcl | 107 | 23 |
| Allopurinol | Allopurinol | 100 | 29 |
| Prednisone | Prednisone | 95 | 45 |
| Carvedilol | Carvedilol | 93 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 90 | 33 |
| Famotidine | Famotidine | 86 | 28 |
| Azithromycin | Azithromycin | 83 | 64 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 82 | 47 |
| Celecoxib | Celecoxib | 82 | 21 |
| Valsartan | Valsartan | 82 | 23 |
| Simvastatin | Simvastatin | 80 | 23 |
| Ibandronate Sodium | Ibandronate Sodium | 79 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 77 | 27 |
| Clonazepam | Clonazepam | 76 | suppressed |
| Xarelto | Rivaroxaban | 76 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 74 | 45 |
| Pregabalin | Pregabalin | 74 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 73 | 25 |
| Donepezil Hcl | Donepezil Hcl | 70 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 70 | 57 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 67 | 20 |
| Buspirone Hcl | Buspirone Hcl | 65 | 14 |
| Finasteride | Finasteride | 63 | 15 |
| Mirtazapine | Mirtazapine | 63 | 17 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 59 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 59 | 17 |
| Methocarbamol | Methocarbamol | 59 | 19 |
| Januvia | Sitagliptin Phosphate | 54 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 51 | 11 |
| Temazepam | Temazepam | 50 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 48 | 14 |
| Trulicity | Dulaglutide | 48 | suppressed |
| Cephalexin | Cephalexin | 47 | 35 |
| Testosterone | Testosterone | 47 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 46 | 21 |
| Ondansetron Odt | Ondansetron | 46 | 29 |
| Promethazine Hcl | Promethazine Hcl | 46 | suppressed |
| Diazepam | Diazepam | 45 | suppressed |
| Novolog | Insulin Aspart | 45 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 44 | 11 |
| Ibuprofen | Ibuprofen | 42 | 15 |
| Levofloxacin | Levofloxacin | 42 | 33 |
| Paroxetine Hcl | Paroxetine Hcl | 41 | 12 |
| Ezetimibe | Ezetimibe | 40 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 40 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 38 | 14 |
| Fluconazole | Fluconazole | 38 | 23 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Linzess | Linaclotide | 38 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 38 | suppressed |
| Spironolactone | Spironolactone | 37 | 12 |
| Sucralfate | Sucralfate | 37 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 36 | 11 |
| Naproxen | Naproxen | 36 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 36 | suppressed |
| Bupropion Xl | Bupropion Hcl | 35 | suppressed |
| Repatha Sureclick | Evolocumab | 35 | suppressed |
| Estradiol | Estradiol | 34 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 33 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 33 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 32 | suppressed |
| Humalog | Insulin Lispro | 32 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 31 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 31 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 31 | suppressed |
| Klor-Con M20 | Potassium Chloride | 31 | 11 |
| Ramipril | Ramipril | 31 | suppressed |
| Methimazole | Methimazole | 30 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | 19 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 27 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 25 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 25 | 14 |
| Paxlovid | Nirmatrelvir/Ritonavir | 25 | 23 |
| Cefdinir | Cefdinir | 24 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Nabumetone | Nabumetone | 24 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Amoxicillin | Amoxicillin | 22 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | 15 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Premarin | Estrogens, Conjugated | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Mounjaro | Tirzepatide | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 18 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 18 | suppressed |
| Eszopiclone | Eszopiclone | 17 | suppressed |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | suppressed |
| Colchicine | Colchicine | 16 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Indapamide | Indapamide | 16 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Progesterone | Progesterone, Micronized | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Insulin Lispro | Insulin Lispro | 14 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Indomethacin | Indomethacin | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Humira Pen | Adalimumab | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Epinephrine | Epinephrine | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $81.68 · 5 records | Medtronic, Inc. | CeQur Simplicity, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, EVENITY, MINIMED 780G, Ozempic, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error